<DOC>
	<DOCNO>NCT00329264</DOCNO>
	<brief_summary>The purpose study demonstrate quetiapine SR ( SEROQUEL® ) efficacious safe acute treatment patient Generalized Anxiety Disorder . PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Safety &amp; Efficacy Study Quetiapine Fumarate ( SEROQUEL® ) v . Placebo Generalized Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient document clinical diagnosis Generalized Anxiety Disorder . Be able understand comply requirement study . Able understand provide write informed consent Patients ( female ) must pregnant lactate Current past diagnosis stroke transient ischemic attack ( TIA ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>GAD</keyword>
	<keyword>anxiety</keyword>
</DOC>